Ascendis Pharma A/S
ASND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612042
In the last 90 days, Ascendis Pharma A/S insiders filed 1 open-market purchase and 2 sales; 313 institutions reported holding it in 13F filings for Q2 2026, worth $17.8B in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Ascendis Pharma A/S changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 215 | 1 | 245 | +31 |
| Shares | 63.8M | 14.4K | 65.2M | +1.44M (+2.3%) |
| Value | $8.78B | $1.99M | $10.1B | +$1.37B (+15.6%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (54)
Institutions that held Ascendis Pharma A/S at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (23)
Institutions that held Ascendis Pharma A/S at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| BIT Capital GmbH | 73,990 | $10.2M |
| Avidity Partners Management LP | 62,000 | $8.54M |
| Thrivent Financial for Lutherans | 35,941 | $4.95M |
| SG Americas Securities, LLC | 33,944 | $4.67M |
| Balyasny Asset Management LLC | 15,419 | $2.12M |
| Maven Securities LTD | 10,000 | $1.38M |
| Simplex Trading, LLC | 6,288 | $865.0K |
| Two Sigma Advisers, LP | 5,400 | $743.4K |
| Cambridge Investment Research Advisors, Inc. | 5,007 | $689.0K |
| Verition Fund Management LLC | 4,300 | $592.0K |
| LMR Partners LLP | 3,100 | $426.8K |
| Virtus ETF Advisers LLC | 2,676 | $368.4K |
| Gsa Capital Partners LLP | 1,717 | $236.0K |
| MML Investors Services, LLC | 1,644 | $226.0K |
| Tobam | 1,622 | $223.0K |
| Sanctuary Advisors, LLC | 1,597 | $203.3K |
| Bayforest Capital Ltd | 1,165 | $160.4K |
| Point72 Asia (Singapore) Pte. Ltd. | 202 | $27.9K |
| Coppell Advisory Solutions LLC | 141 | $19.2K |
| Elequin Capital LP | 53 | $7.30K |
| Eagle Bay Advisors LLC | 23 | $3.20K |
| Allworth Financial LP | 2 | $252 |
| IFP Advisors, Inc | 1 | $138 |
Not filed for Q1 2025 yet (1)
Institutions that held Ascendis Pharma A/S at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 14,430 | $1.99M |